— Know what they know.
Not Investment Advice

NDTP OTC

NDT Pharmaceuticals Inc.
1W: -35.9% 1M: -39.2% 3M: -44.5% YTD: -84.0% 1Y: -78.2% 3Y: -94.8% 5Y: +121328.6%
$0.26
+0.01 (+2.00%)
 
Weekly Expected Move ±23.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 36 · $40.8M mcap · 56M float · 0.0046% daily turnover · Short 41% of daily vol

Cash Flow Trends

Operating Cash Flow
-$18K +0.0% ▲
Capital Expenditures
$3 +0.0% ▲
Free Cash Flow
-$18K +0.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$647 +0.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2006FY2007FY2010FY2014FY2023
— Operating Activities —
Net Income-$52K-$1M-$246K-$261K-$79K
Depreciation & Amort.$0$0$0$0$0
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$4K$13K$232K-$1K$2K
Other Non-Cash Items$17K$984K-$31K$0$5K
Operating Cash Flow-$31K-$39K-$15K-$262K-$18K
— Investing Activities —
Capital Expenditures$0$0$0$0$3
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0-$3
Investing Cash Flow$0$0$0$0$0
— Financing Activities —
Net Debt Issuance$0$25K$0$0$18K
Stock Repurchased$0-$58K$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$500$2K$20K$350K$0
Financing Cash Flow$100K-$30K$20K$350K$18K
Net Change in Cash$69K-$70K$5K$82K$647
Cash End of Period$78K$8K$8K$89K$647
Free Cash Flow-$31K-$39K-$15K-$262K-$18K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms